Today’s news
FDA's Controversial Vaccine Chief Steps Down, Again
Vinay Prasad is heading back to UC San Francisco, per FDA chief Marty Makary

FDA Vaccine Chief Vinay Prasad Departs Agency Again
Prasad's second exit from the FDA follows controversies over vaccine and drug reviews.
FDA Vaccine Chief Departs Agency for Second Time in Less Than a Year
Vinay Prasad leaves the FDA amid controversies over vaccine and drug reviews
Recent news
Mar. 6, 2026
Research Reveals Sensory Impairments in Long COVID Patients
Ohio State study finds broad sensory dysfunctions in long COVID, linked to age, initial severity, and cognitive function
Mar. 5, 2026
Study Finds COVID Lockdowns May Have Stunted Children's Brain Development
Research suggests pandemic disruptions impacted crucial social and cognitive skills in young students.
Mar. 4, 2026
Fungal Supplement Boosts COVID-19 Vaccine Efficacy
Study finds natural fungal supplement reduces side effects and increases antibody durability.
Mar. 4, 2026
RFK Jr. Refuses to Terminate PREP Act Declaration for COVID, Latypova Says
Latypova criticizes Kennedy for not revoking liability protections for COVID vaccine makers
Mar. 3, 2026
Mushroom Supplement Reduced COVID Vaccine Side Effects and Boosted Antibodies
A small clinical trial suggests a mushroom-based supplement could dial down inflammatory side effects from COVID-19 vaccines while strengthening antibody response.
Mar. 3, 2026
Tulane Study Finds COVID-19 Uniquely Impacts Brain, Causing Long-Term Inflammation
Research reveals COVID-19 triggers neurological changes not seen in influenza, potentially explaining 'long COVID' symptoms.
Mar. 3, 2026
Diabetes Drug Metformin Shown to Prevent Long COVID
University of Minnesota researchers find metformin reduces risk of Long COVID by 40-60%
Mar. 2, 2026
Kennedy Faces Backlash from MAHA Allies Over Vaccine Policies
As the midterm elections approach, the health secretary is shifting focus to 'real food,' angering some of his staunchest anti-vaccine supporters.
Mar. 2, 2026
CDC Leadership Turmoil Continues Under Trump Administration
Acting directors rotate through the agency as White House delays naming permanent director
Mar. 1, 2026
Scientists Develop Universal Vaccine for Winter Infections
New approach could protect against common cold, flu, COVID-19 and more.
Feb. 27, 2026
Stanford Researchers Develop Universal Vaccine for Respiratory Threats
Vaccine protects against viruses, bacteria, and allergens in mice, raising hopes for a one-stop solution to seasonal and pandemic respiratory illnesses.
Feb. 27, 2026
15 States Sue HHS Over Changes to Childhood Vaccine Schedule
Vaccine makers could be affected, but legal expert expects them to stay on the sidelines.
Feb. 27, 2026
Novel 'Immune Cocktail' Vaccine Shows Broad Protection Against Infections
Researchers explore a new vaccine paradigm that stimulates the immune system in a non-specific way, offering protection against a range of respiratory pathogens.
Feb. 27, 2026
Colorado Seeks WHO Outbreak Network Membership After US Withdrawal
State leaders aim to maintain access to global health data and early warning systems.
Feb. 27, 2026
Washington State Moves to Issue Its Own Vaccine Guidance
State legislature passes bill to tie vaccine coverage to state recommendations, rejecting federal panel changes
Feb. 26, 2026
Deadly Bird Flu Outbreak Hits California Elephant Seals
H5N1 virus confirmed in seals at Año Nuevo State Park, prompting park closures and warnings about approaching the animals.
Feb. 26, 2026
CDC Vaccine Advisory Panel Meeting Postponed
The highly influential committee's upcoming gathering has been delayed, with no new dates set yet.
Feb. 26, 2026
CDC Vaccine Advisory Panel Meeting Postponed
The highly influential committee's upcoming gathering has been delayed, with no new dates set yet.
Feb. 26, 2026
Infant Immune Response Key to RSV vs. COVID Severity
Study finds differences in immune system reactions to respiratory viruses in young infants
Feb. 25, 2026
CDC Leadership Shakeup Raises Concerns for Hospitals
Acting director appointment and staff departures spark uncertainty around outbreak coordination, public health guidance, and disease surveillance.